In 2025, France BioLead reached a new milestone by further consolidating the French biopharmaceutical manufacturing ecosystem.
In response to the challenges of health sovereignty, innovation, and competitiveness, the Alliance strengthened its role as a unifying force by fostering collaboration, engaging with public authorities, supporting skills development, and driving the emergence of strategic projects.
While significant progress has been made, the momentum generated must now scale up. The 2026–2028 roadmap reflects this ambition: to accelerate the industrial development of the sector and firmly establish France as a leading player in biopharmaceutical manufacturing across Europe.
Download here